对心房动的中风预测因素 - 在CHA2DS2-VA之外
Billy Quirk1, Nicholas D'Elia2, Peter M Kistler2
1Faculty of Medicine, Nursing and Health sciences, Monash University, Melbourne, Australia.
Internal medicine journal
|November 29, 2025
概括
口服抗凝药可以预防心房动中风. 除了CHA2DS2-VA得分之外的新风险因素可以改善这些患者的中风风险预测.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 临床风险分层的临床风险分层
背景情况:
- 口服抗凝药对于管理心房动和预防中风至关重要.
- 目前的风险分层依赖于CHA2DS2-VA得分,在临床实践中存在局限性.
- 改善心房动中风风险预测对于优化抗凝治疗至关重要.
研究的目的:
- 为了确定临床风险因素,生化标志物,心电图特征和超出CHA2DS2-VA得分的心脏成像发现,增加心房动患者中风风险.
- 探索新型风险因素的潜力,以提高现有风险评分的预测准确性.
- 为指导临床医生精细化对心房患者的抗凝药处方决策.
主要方法:
- 对文献的系统审查,确定心房动中的新型中风风险因素.
- 临床风险因素,生化标志物,心电图发现和心脏成像分析.
- 评估目前的CHA2DS2-VA评分系统中不包括的因素.
主要成果:
- 在心房动中,CHA2DS2-VA评分对中风风险分层具有适度的疗效和临床限制.
- 几种新型因素 (临床,生化,心电图,成像) 显示有可能增加中风风险.
- 这些新型因素可能会提高当前风险评估工具的预测能力.
结论:
- 新的风险因素可以增加CHA2DS2-VA得分,以便在心房动中更精确地分层中风风险.
- 整合这些因素可以帮助识别高风险患者最初被认为是低风险的.
- 这种方法支持在心房的管理中个性化抗凝策略.
更多相关视频
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.9K
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
2.0K
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
01:30Acute Coronary Syndrome III: Diagnostic Studies
199
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
199
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
01:30Dysrhythmias V: Evaluating Dysrhythmias
312
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
312